Vanda Pharmaceuticals reported $54.53M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 128.58M 3.32M
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
Akebia Therapeutics AKBA:US USD 19.28M 96.99M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
AstraZeneca AZN:LN USD 8.86B 3M
Bluebird Bio BLUE:US USD 71K 297K
Bristol Myers Squibb BMY:US USD 8.86B 345M
Clovis Oncology CLVS:US USD 22.06M 873K
Eli Lilly And LLY:US USD 5.36B 305M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
Insmed INSM:US USD 54.26M 5.43M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Johnson & Johnson JNJ:US USD 15.94B 56M
Merk MRK:US USD 11.52B 1.08B
Moderna Inc MRNA:US USD 2.26B 1.1B
Novartis NVS:US USD 9.18B 151M
Pfizer PFE:US USD 16.55B 2.52B
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Takeda 4502:JP JPY 696.86B 17.28B
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
Ultragenyx Pharmaceutical RARE:US USD 82.07M 999K
Veracyte VCYT:US USD 49.58M 1.75M